Search results
Researchers find significant racial disparities in who has access to CAR-T therapy
Medical Xpress· 1 day agoPenn Medicine's patients of color are far less likely than white patients to receive a novel gene...
New hope for those living with Sickle Cell Disorder thanks to experimental gene treatment
WSB-TV 2 Atlanta· 4 days agoThe treatment is a gene cell therapy recently approved by the U.S. Food and Drug Administration. For...
Most stem cells die after being injected into the brain. This new technique could change that
Medical Xpress· 6 days agoMultiple sclerosis (MS) is the most common demyelinating disease, affecting more than 2.5 million...
Cancer Breakthrough: Scientists Discover Game-Changing New Type of T Cells
SciTechDaily· 6 days agoResearchers from the University of Houston identified CD8-fit T cells with high motility and serial...
Lisata Therapeutics (NASDAQ:LSTA) Stock Price Up 6.4%
ETF DAILY NEWS· 15 hours agoLisata Therapeutics, Inc. (NASDAQ:LSTA – Get Free Report) shares traded up 6.4% on Tuesday . The stock traded as high as $3.70 and last traded at $3.67. 44,934 shares changed hands during trading ...
BlueSphere Bio's huge week with FDA approval for dosing and National Cancer Institute agreement -...
The Business Journals· 5 days agoBlueSphere Bio, a UPMC Enterprises spinout and Pittsburgh-based drug development company, logged a big week in its development with a clearance from the U.S. Food and Drug Administration and ...
ProKidney (NASDAQ:PROK) Given New $6.00 Price Target at Jefferies Financial Group
ETF DAILY NEWS· 2 days agoProKidney (NASDAQ:PROK – Free Report) had its target price reduced by Jefferies Financial Group from $15.00 to $6.00 in a research note released on Monday, Benzinga reports. Jefferies Financial ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 5 days agoWARREN, N.J., June 07, 2024 (GLOBE NEWSWIRE) -- A release was issued under a similar headline on Thursday, June 6th by Tevogen Bio Holdings Inc. (Nasdaq: TVGN). Please note that the second paragraph has been corrected and a photo is now included
CAR-T therapy is considered a cure for some types of cancer. Penn researchers found significant...
Philly.com· 2 days agoResearchers at the University of Pennsylvania found significant racial disparities in who gets...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 6 days agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
